ERBB2 and breast cancer: The detection of the biological markers of BC, such as progesterone receptor (PR), estrogen receptor (ER), and tyrosine kinase ErbB2 receptor (HER2), can better predict the treatment and prognosis of patients (Onitilo et al., 2009).